Publications

The impact of changing the diagnostic algorithm for TB in Manicaland, Zimbabwe.

Zvinoera, K; OLARU, ID; KHAN, P; Mutsvangwa, J; Denkinger, CM; Kampira, V; Coutinho, D; Mutunzi, H; Pepukai, M; Chikaka, E; Zinyowera, S; Mharakurwa, S; KRANZER, K;

2021

Public health action, (2021).11 4 10.5588/pha.21.0040.

How much healthcare is wasted? A cross-sectional study of outpatient overprovision in private-for-profit and faith-based health facilities in Tanzania.

KING, JJ C; POWELL-JACKSON, T; Makungu, C; HARGREAVES, J; GOODMAN, C;

2021

Health policy and planning, (2021).36 5 10.1093/heapol/czab039.

Probing Differences in Gene Essentiality Between the Human and Animal Adapted Lineages of the Mycobacterium tuberculosis Complex Using TnSeq.

Gibson, AJ; PASSMORE, IJ; Faulkner, V; Xia, D; Nobeli, I; Stiens, J; WILLCOCKS, S; CLARK, TG; Sobkowiak, B; Werling, D; Villarreal-Ramos, B; WREN, BW; Kendall, SL;

2021

Frontiers in veterinary science, (2021).8, 10.3389/fvets.2021.760717.

Social contact information from PIPSA residents in uMkhanyakude before and during the Covid-19 pandemic – data from the Umoya Omuhle and Covid Social Contacts studies.

MCCREESH, N; Dlamini, V; Edwards, A; Olivier, S; Dayi, N; Dikgale, K; Nxumalo, S; Dreyer, J; BAISLEY, K; Siedner, MJ; WHITE, RG; Herbst, K; GRANT, AD; Harling, G;

2021

, AHRI Data Repository (2021).

The effect of a structured clinical algorithm on glycemic control in patients with combined tuberculosis and diabetes in Indonesia: A randomized trial.

Ruslami, R; Koesoemadinata, RC; Soetedjo, NN M; Imaculata, S; Gunawan, Y; Permana, H; Santoso, P; Alisjahbana, B; McAllister, SM; GRINT, D; Critchley, JA; Hill, PC; Van Crevel, R;

2021

Diabetes research and clinical practice, (2021).173, 10.1016/j.diabres.2021.108701.

Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the 'POPulation differences in VACcine responses' (P...

NATUKUNDA, A; NKURUNUNGI, G; ZIRIMENYA, L; Nassuuna, J; Oduru, G; Amongin, R; Kabuubi, PN; Mutebe, A; Onen, C; Amongi, S; Nakazibwe, E; Akello, F; Kiwanuka, S; Kiwudhu, F; Sewankambo, M; Nsubuga, D; Kizindo, R; STAEDKE, SG; COSE, S; WEBB, E; ELLIOTT, AM; POPVAC trial team,;

2021

BMJ open, (2021).11 2 10.1136/bmjopen-2020-040427.

Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa.

MCCREESH, N; Karat, A; GOVENDER, I; BAISLEY, K; Diaconu, K; Yates, T; HOUBEN, RM G J; Kielmann, K; GRANT, A; WHITE, R;

2021

medRxiv (2021). 10.1101/2021.08.02.21260844.

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells.

Tanner, R; Hoogkamer, E; Bitencourt, J; White, A; Boot, C; Sombroek, CC; Harris, SA; O'Shea, MK; Wright, D; Wittenberg, R; Sarfas, C; Satti, I; Verreck, FA W; Sharpe, SA; FLETCHER, HA; McShane, H;

2021

F1000Research, (2021).10, 10.12688/f1000research.51640.2.

Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward.

Olbrich, L; Stockdale, L; BASU ROY, R; Song, R; Cicin-Sain, L; Whittaker, E; Prendergast, AJ; FLETCHER, H; Seddon, JA;

2021

PLOS PATHOGENS, (2021).17 12 10.1371/journal.ppat.1010061.

Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0-4 years.

Thysen, SM; Fisker, AB; Byberg, S; Aaby, P; Roy, P; WHITE, R; Griffiths, U; Harris, RC;

2021

BMJ global health, (2021).6 8 10.1136/bmjgh-2021-006127.